Alucent Biomedical, Inc. – Trademark Portfolio
Entity Type: 03
Alucent Biomedical, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ALUCENT NVS and ALUCENT NVS VESSEL RESTORATION SYSTEM. The owner is based in Salt Lake City, UT.
675 Arapeen Drive, Ste. 102
Salt Lake City, UT 84108
Showing of trademarks Trademarks
Trademark Classifications
Alucent Biomedical, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Alucent Biomedical, Inc. have?
Alucent Biomedical, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 3 cancelled.
What trademark classes does Alucent Biomedical, Inc. file in?
Alucent Biomedical, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Alucent Biomedical, Inc.'s most well-known trademarks?
Alucent Biomedical, Inc.'s registered trademark portfolio includes well-known marks such as ALUCENT NVS and ALUCENT NVS VESSEL RESTORATION SYSTEM. These are among 2 currently registered trademarks in the portfolio.
What is Alucent Biomedical, Inc.'s trademark registration success rate?
Alucent Biomedical, Inc. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.